Stocktoria
Galmed Pharmaceuticals Ltd. GLMD
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2014-03-13
Galmed Pharmaceuticals Ltd. statistics & valuation
Market cap$4.4M
P / B0.3×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -55.3% | -40.6% | -41.6% | -107.9% | -88.7% |
| Return on equity | -65.3% | -46.0% | -49.8% | -133.1% | -106.5% |
| Current ratio | 6.55 | 7.42 | 4.81 | 4.76 | 6.13 |
Source: SEC EDGAR filings · CIK 0001595353 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.